What is the ticker symbol for Assembly Biosciences?

Assembly Biosciences trades under the ticker ASMB on NASDAQ.

What sector does Assembly Biosciences operate in?

Assembly Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ASMB in a portfolio?

PortView shows ASMB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Assembly Biosciences (ASMB) Stock Analysis

NASDAQHealthcareBiotechnology

$35.64+1.29%

1-year price historyRange $20.55 – $38.50

52-week range$35.64

$20.23$39.71

What Assembly Biosciences does

Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections within the United States. Its primary drug candidate, Vebicorvir, has successfully concluded Phase 2 clinical trials for individuals with chronic HBV. The company's development pipeline also features ABI-H3733, which has finished Phase 1a clinical studies, and ABI-4334, currently in pre-clinical assessment for HBV treatment. Assembly Biosciences has forged collaborative partnerships, including agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation, as well as with Antios Therapeutics, Inc., to explore a triple-combination treatment strategy for chronic hepatitis B virus. Additionally, it maintains strategic licensing arrangements with Indiana University Research and Technology Corporation and Door Pharmaceuticals, LLC. Established in 2005, the company was formerly known as Ventrus Biosciences, Inc. before rebranding to Assembly Biosciences, Inc. in June 2014, and its headquarters are located in South San Francisco, California.

Key metrics

Market cap

$706.19M

P/E (TTM)

-323.96

EPS (TTM)

$-0.11

Beta

1.09

Dividend yield

0.00%

Revenue / share

$3.97

50-day avg

$28.53

200-day avg

$29.30

52-week high

$39.71

52-week low

$20.23

CEO

Jason A. Okazaki

ETFs linked to ASMB

Broad-market and Healthcare sector ETFs an investor holding Assembly Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ASMB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ASMB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Assembly Biosciences?: Assembly Biosciences trades under the ticker ASMB on NASDAQ.
Which exchange is ASMB listed on?: ASMB is listed on NASDAQ.
What sector does Assembly Biosciences operate in?: Assembly Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ASMB in a portfolio?: PortView shows ASMB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.